Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Phosphodiesterase 1A (PDE1A) is an enzyme that hydrolyzes cyclic nucleotides, specifically cAMP and cGMP, and its activity is stimulated by calcium/calmodulin. It plays a role in regulating various signaling pathways, particularly in cardiovascular tissues, the central nervous system, and other tissues. By controlling cAMP and cGMP levels, it influences processes such as vascular smooth muscle cell growth, survival, proliferation, and apoptosis. PDE1A is implicated in diseases such as hypertension, pulmonary arterial hypertension, metabolic syndrome, Fraser Syndrome and Nephrolithiasis.
Inhibition of PDE1A increases intracellular cAMP and cGMP levels.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phosphodiesterase 1A (PDE1A).